Moreover, METTL3 could positively regulate PLOD2 expression in RCC, which was confirmed by gene expression profiling interactive analysis (GEPIA2) (P = 6e-09, Fig. 3E). The gene discussed is PLOD2; the disease is renal cell carcinoma.